Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

28
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
28
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

851
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
851
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.8K
Drug Discovery: Overview01:26

Drug Discovery: Overview

9.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.5K
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

17
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
17
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine Learning Models Can Predict Tinnitus and Noise-Induced Hearing Loss.

Ear and hearing·2025
Same author

Correction to: Tinnitus, sound intolerance, and mental health: the role of long-term occupational noise exposure.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2022
Same author

Tinnitus, sound intolerance, and mental health: the role of long-term occupational noise exposure.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2022
Same author

Noise Damage Accelerates Auditory Aging and Tinnitus: A Canadian Population-Based Study.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2020
Same author

Extrusion of barley and oat influence the fecal microbiota and SCFA profile of growing pigs.

Food & function·2016
Same author

Extrusion of barley and oat improves the bioaccessibility of dietary phenolic acids in growing pigs.

Journal of agricultural and food chemistry·2013

Related Experiment Video

Updated: Oct 15, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.8K

Digitalization in pharmaceutical industry: What to focus on under the digital implementation process?

Glenn Hole1, Anastasia S Hole2, Ian McFalone-Shaw1

  • 1Molde University College, Molde and Procuratio Consulting, Drammen, Norway.

International Journal of Pharmaceutics: X
|October 29, 2021
PubMed
Summary

Digitalizing the pharmaceutical industry, especially Contract Development Manufacture Organizations (CDMOs), is crucial for meeting growing drug demands. This involves integrating automation and computerization while maintaining strict Good Manufacture Practice (GMP) standards.

Keywords:
AIDS, Acquired Immune Deficiency SyndromeCDMO, Contract Development and Manufacturing OrganizationContract development manufacture organizationDigitalizationEMA, European Medicines AgencyEU, European UnionFDA, Food and Drug AdministrationGMP, Good Manufacturing PracticeITA., International Trade AdministrationMHRA, Medicines and Healthcare Products Regulatory AgencyPAI, Pre-Approval InspectionsPI, Pharmaceutical IndustryPharmaceutical industryProcess improvementsTDM, Traditional Drug ManufacturingUSD, United States Dollars

More Related Videos

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

8.8K
Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.4K

Related Experiment Videos

Last Updated: Oct 15, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.8K
Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

8.8K
Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.4K

Area of Science:

  • Pharmaceutical manufacturing
  • Industrial digitalization
  • Process optimization

Background:

  • The pharmaceutical industry (PI) has historically resisted digitalization due to process complexity and regulatory hurdles.
  • Growing demand for traditional and novel drugs necessitates increased efficiency and flexibility in PI.
  • Contract Development Manufacture Organizations (CDMOs) face unique challenges in adopting digital technologies.

Purpose of the Study:

  • To provide an overview of key aspects in CDMO digitalization.
  • To discuss the opportunities and challenges associated with digital implementation in CDMOs.
  • To highlight practical solutions for successful digital transformation in the pharmaceutical sector.

Main Methods:

  • Literature review of digitalization trends in manufacturing.
  • Analysis of challenges specific to the pharmaceutical sector and CDMOs.
  • Examination of the interplay between digitalization and Good Manufacture Practice (GMP).

Main Results:

  • Digitalization offers significant benefits, including cost reduction, enhanced efficiency, and improved flexibility.
  • Successful digitalization in CDMOs requires a strong focus on GMP compliance.
  • Effective stakeholder collaboration is essential for navigating the complexities of digital transformation.

Conclusions:

  • Digitalization is imperative for the pharmaceutical industry's growth and adaptability.
  • CDMOs must strategically integrate digital solutions while adhering to stringent regulatory requirements.
  • A phased approach focusing on GMP and stakeholder engagement is key to successful digitalization.